E-Prescribing Market Outlook, Growth Prospects and Key Opportunities

E-Prescribing system facilities the practitioner to generate a new prescription electronically whenever treatment error occurs during healthcare operations. E-Prescribing system offers extensive range of applications. It provides comprehensive form of medical data, ensures all security checks and patents identification. It offers complete privacy to the disease information and patient’s identification with present and historical data.

Based on the different product type the global e-prescribing market can be broadly classified as, stand-alone systems, and integrated systems. Based on the different components of electronics prescribing the global e-prescribing market can be segmented as software and hardware (including access devices, peripherals, servers, storage devices, and networking devices) and services (including consulting, implementation services, post-sale & maintenance and training services). On the bases of mode of the delivery of the e-prescription the global e-prescription market can be classified as on premise, web-based and cloud. Further, based on the end user application the market can be segmented as hospitals and office-based physicians.

Europe was the largest market of e-prescription in 2013, followed by North America and Asia Pacific region. The market of e-prescription in Middle East, and Africa are in nascent stage. Asia Pacific and North America are two of the fastest growing market of the E-prescription. Country wise, U.S. is the largest market of e-prescription in North America. Germany, Italy, and Spain are some of the major market of e-prescription in Europe. In Asia Pacific, China, Japan, and India are fastest growing market of e-prescription attributed mainly to the strengthening healthcare services and advancement of the information technology in this region.

Major Competitors: The global e-prescription market is dominated by Bioclinica, Inc., Bizmatics Inc., CRF Health, DATARAK International, Inc., eResearch Technology, Inc., Some of the top competitors in the global clinical trial management system market are e-MDs, Inc., iMedX, Inc., Practice Fusion, Inc., SureScripts-RxHub, LLC, eClinicalWorks, LLC, and Quality System, Inc.

Read More

Technological Advancements Strengthening Cleanroom Technology Market

The favorable healthcare regulations, rapid developments in technology, and surging prevalence of infectious diseases are some of the key factors responsible for the growth of the cleanroom technology market. In 2016, the market attained a size of $3.4 billion, and it is expected to generate a revenue of $5.0 billion by 2023, progressing at a 5.7% CAGR during the forecast period (2017–2023). A cleanroom is an enclosed space, which is built to prevent harmful substances released by various airborne particles, including microorganisms, chemicals, and harmful radiations, such as ultraviolet rays, from polluting the space.

Based on end user, the cleanroom technology market is categorized into medical device, biotechnology industry, and pharmaceutical industry. Out of these, in 2016, the pharmaceutical industry held the largest revenue share of more than 40.0% in the market, and it is predicted to continue leading it during the 2017–2023 period. This is attributed to the expanding biopharmaceutical sector, which is accelerating the manufacturing of pharmaceutical products across the globe. As per the United States Food and Drug Administration, it is essential to implement specified guidelines for all food and pharmaceutical industries.

The global cleanroom technology market has been witnessing various technological developments, which are helping in improving the efficiency of cleanrooms with the high production of advanced sterile products. These upgraded products aid in providing a cleaner environment to manufacture products. Also, these developments help in minimizing the defects in cleanroom designs and workflow, which is further predicted to surge the demand for cleanrooms. Technological developments in equipment, such as heating, ventilation, and air conditioning systems and high-efficiency particulate air (HEPA) filters, offer better functionality of cleanrooms.

HEPA filters absorb nano-sized toxic compounds and improve the filtration process, which reduces the time taken for purifying the area. Additionally, the presence of modular cleanrooms, which are enclosed structures equipped with all devices, is expected to surge the production of cleanrooms, globally. In addition, customized cleanrooms are rapidly gaining popularity in the cleanroom technology market. Pressure, temperature, electrostatic charge, humidity, and magnetic flux can be modified as per customers’ need in a customized cleanroom. These cleanrooms are essential for research and development activities in the medical device, pharmaceutical, and biotechnology sectors.

Hence, the surging incidence of infectious diseases, technological advancements, and growing demand for customized cleanrooms are driving the growth of the market.

Read More

mHealth Market - Business Opportunities and Investment Research Report 2023

The global mHealth market is being driven by the increasing penetration of tablets and smartphones, and growing adoption of connected healthcare devices and mHealth apps. Rising geriatric population prone to chronic diseases, increasing focus on patent-centric healthcare, and growing demand for remote patient monitoring are also helping in this regard. Generating a revenue of $23.0 billion in 2017 as per a P&S Intelligence study, the market is predicted to advance through the forecast period 2018–2023 at a CAGR of 33.5%!

mHealth refers to the collection of medical data and delivery of healthcare services via mobile phones and tablets. On the basis of offering, the mHealth market can be divided into mHealth apps, connected devices, and services. Among these, the connected devices category led the market in 2017 with 57.2% share, due to a growing demand for remote patient monitoring solutions. In places, where people’s houses and healthcare centers are distant, these collect patients’ medical data and send it to medical practitioners via the internet, thus allowing for real-time disease management and improved patient outcomes.

Among the several types of connected devices available are blood pressure monitors, blood glucose monitors, multiparameter monitors, echocardiography (ECG) monitors, sleep apnea monitors, pulse oximeters, and others. In 2017, blood pressure monitors held the largest revenue share (28.7%) in the mHealth market owing to an increased prevalence of chronic disease and the easy mobility of such devices. While blood pressure monitors will still be the market leader during the forecast period, blood glucose monitors will witness the highest CAGR (31.9%) due to the increasing number of diabetes patients.

By recording and sharing medical data, connected devices and mHealth apps also lower the healthcare expenditure by minimizing hospital readmissions, clinic revisits, medical tests, and other physical examinations. A study, conducted by New York University, Harbin Institute of Technology and Carnegie Mellon University between 2015 and 2016, showed that mHealth helped reduce the glycated hemoglobin and blood glucose levels, hospital visits, and medical expenses of type 2 diabetes patients.

Therefore, it is clear that the growing prevalence of chronic diseases and the need to reduce healthcare costs will take the domain forward.

Read More

Top Key Players Operating In the Population Health Management Market and Growth Strategies

The population health management industry size is set to cross $48.1 billion by 2022. The growing geriatric population, increasing prevalence of chronic diseases, Affordable Care Act, increasing investments by HIT players and increasing healthcare spending are driving the growth of the PHM market.

The market for PHM in the European region is expected to cross $4.7 billion by 2022. The major factors driving the growth of the European population health management market include increase in demand for reducing healthcare cost, high prevalence of chronic diseases and increasing government initiatives. Aging population is another key factor driving the growth of the population health management industry in the region. The geriatric population is more susceptible to acquire diseases and hence, is at a higher risk of suffering from chronic diseases. Among the countries of the European region, Germany was the largest market for PHM, which is expected to grow at a CAGR of 22.8% during the forecast period to reach $1.5 billion by 2022.

Global Population Health Management Market Segmentation

By Delivery Mode

• Web based
• Cloud based
• On-premise

By Component

• Software
• Service

By End User

• Healthcare provider
• Healthcare payer
• Employer group
• Government bodies

By Geography

• North America
• U.S.
• Rest of North America
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia
• Japan
• Rest of Asia
• Rest of the World (RoW)

Emerging economies offer huge market potential

Although, the population health management market is largely concentrated in the U.S., emerging economies such as China, India and Brazil offer ample growth opportunities. Huge unexplored market in the Asia and other developing regions create huge revenue generation opportunities for PHM vendors. The healthcare industry is witnessing significant growth in these countries. In addition, the large population base and improving healthcare infrastructure create suitable platform for the penetration of PHM in these countries.

Competitive Analysis

Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., Wellcentive Inc., Conifer Health Solutions LLC., IBM Corporation, Optum, Inc., and Health Catalyst LLC are some of the key companies operating in the population health management market.

Read More

Biotech News: Protein Expression Market to Grow at a Brisk Rate in the Foreseeable Future

A recent research report published by P&S Intelligence on the protein expression market predicts that the market will have a healthy growth for the next few years. According to the report, the size of the protein expression market is projected to reach $3.0 billion by 2023. Increasing prevalence of chronic diseases, aging population, increase in growth in life science sector, availability of funding for protein-based research and technological advancements are key drivers for the growth of market.

Recombinant production of proteins is one of the most powerful molecular biology techniques used in the life sciences sector for its industrial application in producing biopharmaceuticals. The ability of producing abundant volume of purified and desired recombinant protein leads to its extensive potential application such as, in industrial processes, or its use to diagnose or treat diseases. Increase in research to understand efficient expression of novel and difficult proteins through protein and cell line engineering is an essential step to support future drug discoveries. A major prerequisite for drug discovery is that recombinant proteins can be produced in adequate amount and are of appropriate quality. Major players are focusing on expanding their research activities and investing on recombinant based protein expression for production of large volume of recombinant protein to be used as biotherapeutics and are also to support drug discoveries.

Geographically, the Asia-Pacific protein expression market has been experiencing growth due increasing prevalence of diseases such as anaphylaxis and diabetes, increasing aging population, increased R&D spending, and increasing per capita income. According to International Diabetes Federation, China, India, Brazil, Bangladesh and Indonesia are the top five countries with high number of diabetic patients and have emerged as a potential market for protein expression.

The global protein expression market is highly consolidated as the top three companies constitute for two-thirds of the overall market share in 2016. ThermoFisher Scientific Inc., Merck KGaA and Agilent Technologies led the global market in 2016. ThermoFisher Scientific Inc. held almost one-third of the global protein expression market share in 2016, primarily due to the availability of protein expression products as prokaryotic, mammalian, insect cell, yeast, cell free and algae-based systems. Merck KGaA was the second largest player in global protein expression market in 2016. There is stiff competition among Promega Corporation, New England Biolabs Inc. and Takara Bio. Inc. in the global market as only these companies market cell-free based protein expression systems. 

Other major players in the market are Qiagen N.V., Lonza Group Ltd., Genscript Biotech Corporation, New England Biolabs Inc. and Bio-Rad Laboratories, Inc.

Read More

Rising Number of Surgical Procedure Supporting Fibrin Glue Growth

The fibrin glue market is projected to grow during the forecast period (2017–2023) at a CAGR of 10.9% owing to the surging number of burn cases and surgical procedures and increasing healthcare expenditure. In addition, the growing prevalence of chronic diseases, increasing geriatric population, and rising road accidents are supporting to market advance. Fibrin glue is a kind of tissue adhesive extracted from a human or animal source, which is primarily used for healing wounds, coagulating the blood, tackling hemorrhage, and sealing tissues.

Learn more about this report: http://bit.ly/2YYjeNf

Geographically, during 2013–2016, North America led the fibrin glue market, with the U.S. being the larger contributor compared to Canada. The increasing prevalence of cardiovascular diseases is a prime reason behind the growth of the North American market for cardiac surgery. In addition, the rising number of surgical procedures, mainly plastic surgery, in the region, surging aging population, high expenditure on healthcare, and significant number of burn cases and road accidents are boosting the use of fibrin glue.

As per the American Heart Association, in the U.S., nearly 85.6 million people are suffering from cardiovascular diseases. Further, the growing healthcare spending is being witnessed as the key factor driving the growth of the fibrin glue market. The healthcare expenditure includes the public and private spending on medical goods and services, public health and prevention programs, and administration. As per the Centers for Disease Control and Prevention (CDC), in the U.S., in 2014, the total health expenditure was $3.0 trillion and the per capita national health expenditure was $9,523.

European fibrin glue market is the second largest in the world

Europe is the second largest market for fibrin glue products, accounting for 24.4% of the global fibrin glue industry in 2016. The growth in the European fibrin glue market is mainly attributable to the increasing aging population and rising number of surgical procedures performed for the treatment of the circulatory system diseases in the region. Among the countries in Europe, Germany held the largest share of the European market for fibrin glue, contributing 26.2% in 2016. However, the market in France is expected to witness the highest growth during the forecast period. France was also the second largest market for fibrin glue products in 2016 in Europe, accounting for a 14.6% share, which is expected to increase to 15.5% by 2023, growing at a CAGR of 10.7% during the forecast period. The U.K. is the third largest market in Europe and is also expected to witness double digit growth during the forecast period.

Competitive Analysis

Vivostat A/S, Kaketsuken, Johnson & Johnson, Baxter International Inc., CSL Behring, Zimmer Biomet Holdings, Inc., Takeda Pharmaceutical Company Limited, Mallinckrodt Plc, Shanghai RAAS Blood Products Co. Ltd. and Hualan Biological Engineering Inc are Some of the key players operating in the global fibrin glue market.

Read More

Molecular Biology Kits and Enzymes & Reagents Market Forecast to 2022

The surging aging population and growing prevalence of infectious diseases are heavily accelerating the demand for molecular biology products, thereby resulting in the growth of the molecular biology kits & reagents and enzymes market. In 2015, the market generated revenue of $4,928.3 million, and it is expected to advance at a CAGR of 17.2% during the forecast period (2016–2022). Molecular biology kits, reagents, and enzymes are used to perform RNA analysis, cloning, protein analysis, DNA isolation, polymerase chain reaction (PCR), and DNA sequencing.

Based on product, the molecular biology kits & reagents and enzymes market is bifurcated into kits & reagents and enzymes. Of these, during the historical period (2012–2015), kits & reagents dominated the market in terms of revenue, and these are predicted to maintain their dominance during the 2016–2022 period. This is attributed to the high demand for such products owing to the surging research applications, growing geriatric population, and increasing healthcare expenditure. Kits and reagents are adopted for automated processes, but these can also be used manually for several research purposes.

Learn more about this report: http://bit.ly/2GRBk9n

This population is predicted to surge by 56.0% globally, i.e. from 901 million in 2015 to 1.4 billion by 2030 and more than double after 2015 to reach 2.1 billion by 2050. The surging elderly population in Germany, the U.S., China, and India is projected to create a high demand for molecular biology enzymes, kits and reagents, which, in turn, would result in the growth of the molecular biology kits and reagents and enzymes market.

Furthermore, due to the rapid growth in the number of people suffering from cancer and infectious diseases, the demand for such products is on the rise. The prevalence of acquired immune deficiency syndrome, hepatitis C, and healthcare-associated infections is expected to grow during the forecast period owing to poor lifestyle and lack of access to preventive care. In 2014, in the U.S., as per the American Cancer Society, nearly 484,340 new cases of cancer were registered in people aged 65 years and above.

Thus, the rising incidence of cancer and infectious diseases and surging geriatric population are contributing to the growth of the market.

Read More

At-Home Drug of Abuse (DOA) Testing Rescuing Addicts from the Shadows

Nowadays, drugs are as much a cause for concern as, say, terrorism or global warming. Cannabis, cocaine, heroin…there are so many drugs available across the world and that too with relative ease. What is disheartening is that despite rising awareness and government efforts, the number of drug users doesn’t seem to be falling fast. As per a report published by the United Nations Office on Drugs and Crime (UNODC), the worldwide number of drug users remained almost stable in 2016. All this has resulted in the emergence of drug testing products that help in the effective detection of drugs in users’ body, hence driving the growth of at-home drug of abuse (DOA) testing market.

Learn more about this report: http://bit.ly/2YOoaUs

The major factors assisting in the growth of the market are rising addiction among teenagers and increased manufacturing and trade of such substances. As per the UNODC report cited above, Afghanistan was the major contributor to global drug production in 2017, where the total opium cultivation area and amount of produce rose rapidly in the past few years. Apart from production, family issues, peer pressure, and reduced self-esteem are resulting in increased drug addiction among teenagers, enhancing the scope for the at-home drug of abuse (DOA) testing market worldwide.

In an endeavor toward timely detection of drugs for teenagers to receive effective counseling and treatment, educational institutions and families are spending more on testing instruments, which is, in turn, driving the growth of at-home drug of abuse testing market. Rapid DOA test kits and breath analyzers are the two broad categories of the market by type. Of the two, rapid DOA test kits are more commonly used at homes and colleges.

Geographically, the North American continent occupies the largest at-home drug of abuse testing market share, primarily owing to the increasing incidence of drug trafficking and easy availability of these substances in the region. As far as specific drug types are concerned, bath salts and synthetic cannabinoids are the preferred means to get high; therefore, the major players in the domain are specially focusing on these. Companies in the market are coming with innovative products that help in the detection of these particular substances along with other illicit drugs. For instance, UCP Biosciences Inc. announced the launch of its u-Cup DOA testing cups in 2018. It also announced that these would be available in various sizes and shapes.

Seeing the rapid growth in the sector, it is being hoped that intoxication by drugs is caught early in troubled teenagers and that they receive all the emotional and therapeutic support they require.

Read More